Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753926-25-000019
Filing Date
2025-01-03
Accepted
2025-01-03 21:22:55
Documents
2
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8369
2 EXHIBIT 24.1 g084637_ex24-1.htm EX-24.1 53816
  Complete submission text file 0001753926-25-000019.txt   63761
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Issuer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208
Business Address
Kaufman Jonathan H (Reporting) CIK: 0001959250 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41575 | Film No.: 25508820